Nifty

:

16352.45

Sensex

:

54884.66

182.30 (1.13%)
632.13 (1.17%)

Login

Nifty
Sensex

:
:

16352.45
54884.66

182.30 (1.13%)
632.13 (1.17%)

Krebs Biochemicals & Industries Ltd.

Pharmaceuticals & Drugs

Rating :

49/99

BSE: 524518 | NSE: KREBSBIO

Watchlist

NSE BSE

116.75

27-May-2022

Open
High
Low
Previous Close

116.90
119.00
115.30
114.70

Volume
Traded Value (lacs)
52 Week High
52 Week Low

13851
16.32
227.90
110.65

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

248.27
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

348.70
N/A
-3.32

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-2.72
72.36
3.98

EBITDA CAGR (%)

10 Years
5 Years
3 Years

16.61
17.05
12.49

PAT CAGR (%)

10 Years
5 Years
3 Years

4.98
12.06
12.33

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-7.61
-7.61
-7.61

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-15.76
-24.41
-16.04

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 22 Mar 21 Var% Dec 21 Dec 20 Var% Sep 21 Sep 20 Var% Jun 21 Jun 20 Var%
Net Sales 19.16 15.86 20.81% 21.81 9.58 127.66% 11.98 16.69 -28.22% 6.75 11.57 -41.66%
Expenses 28.94 20.38 42.00% 31.71 15.23 108.21% 19.77 19.79 -0.10% 13.28 15.87 -16.32%
EBITDA -9.78 -4.53 - -9.90 -5.65 - -7.79 -3.10 - -6.53 -4.30 -
EBIDTM -51.04% -28.53% -45.41% -59.00% -65.01% -18.56% -96.61% -37.19%
Other Income 0.79 0.44 79.55% 0.20 0.06 233.33% 0.13 0.07 85.71% 0.03 0.05 -40.00%
Interest 0.28 1.49 -81.21% 1.82 1.43 27.27% 1.78 2.13 -16.43% 1.51 1.23 22.76%
Depreciation 2.05 1.41 45.39% 1.42 1.24 14.52% 1.42 1.24 14.52% 1.42 1.24 14.52%
PBT -11.31 -6.99 - -12.94 -8.26 - -10.85 -6.39 - -9.42 -6.72 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT -11.31 -6.99 - -12.94 -8.26 - -10.85 -6.39 - -9.42 -6.72 -
PATM -59.06% -44.06% -59.34% -86.25% -90.55% -38.28% -139.51% -58.09%
EPS -5.24 -3.23 - -5.99 -3.82 - -5.02 -2.96 - -4.36 -3.11 -

Description Dec 21 Dec 20 Var% Sep 21 Sep 20 Var% Jun 21 Jun 20 Var% Mar 21 Mar 20 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13 Mar 12
Net Sales 59.70 53.70 33.41 47.76 33.78 3.53 1.29 0.00 0.00 11.45 70.76 Net Sales Growth 11.17% 60.73% -30.05% 41.39% 856.94% 173.64% 0 0 -100% -83.82% Cost Of Goods Sold 40.64 25.94 15.86 23.10 12.67 1.20 0.14 0.00 0.00 4.61 38.70 Gross Profit 19.06 27.75 17.55 24.65 21.10 2.33 1.14 0.00 0.00 6.83 32.06 GP Margin 31.93% 51.68% 52.53% 51.61% 62.46% 66.01% 88.37% 0 0 59.65% 45.31% Total Expenditure 93.70 71.28 51.97 57.52 41.28 11.53 13.69 4.90 4.04 24.63 74.54 Power & Fuel Cost - 15.91 10.28 11.70 8.62 0.70 2.87 0.28 1.87 6.24 18.79 % Of Sales - 29.63% 30.77% 24.50% 25.52% 19.83% 222.48% 0 0 54.50% 26.55% Employee Cost - 15.30 14.56 14.41 11.49 5.63 5.67 1.86 0.55 9.08 8.77 % Of Sales - 28.49% 43.58% 30.17% 34.01% 159.49% 439.53% 0 0 79.30% 12.39% Manufacturing Exp. - 10.37 6.77 4.09 4.59 1.07 1.62 0.62 0.04 1.76 3.57 % Of Sales - 19.31% 20.26% 8.56% 13.59% 30.31% 125.58% 0 0 15.37% 5.05% General & Admin Exp. - 3.47 4.05 4.05 3.76 2.88 3.33 2.14 1.54 2.57 2.36 % Of Sales - 6.46% 12.12% 8.48% 11.13% 81.59% 258.14% 0 0 22.45% 3.34% Selling & Distn. Exp. - 0.14 0.16 0.13 0.13 0.05 0.04 0.00 0.01 0.29 2.31 % Of Sales - 0.26% 0.48% 0.27% 0.38% 1.42% 3.10% 0 0 2.53% 3.26% Miscellaneous Exp. - 0.13 0.29 0.02 0.02 0.01 0.02 0.00 0.03 0.06 2.31 % Of Sales - 0.24% 0.87% 0.04% 0.06% 0.28% 1.55% 0 0 0.52% 0.06% EBITDA -34.00 -17.58 -18.56 -9.76 -7.50 -8.00 -12.40 -4.90 -4.04 -13.18 -3.78 EBITDA Margin -56.95% -32.74% -55.55% -20.44% -22.20% -226.63% -961.24% 0 0 -115.11% -5.34% Other Income 1.15 0.62 0.37 0.33 0.21 0.08 1.03 0.01 0.18 6.14 2.75 Interest 5.39 6.28 6.00 6.29 5.17 3.49 0.74 4.03 0.08 0.63 8.66 Depreciation 6.31 5.12 4.68 4.40 4.15 4.23 4.49 1.87 0.00 8.28 9.66 PBT -44.52 -28.36 -28.87 -20.12 -16.61 -15.65 -16.60 -10.79 -3.95 -15.94 -19.34 Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.40 -0.74 -1.90 Tax Rate 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -10.13% 4.64% 9.82% PAT -44.52 -28.36 -28.87 -20.01 -17.82 -16.05 -16.32 -7.84 -4.35 -15.20 -17.44 PAT before Minority Interest -44.52 -28.36 -28.87 -20.01 -17.82 -16.05 -16.32 -7.84 -4.35 -15.20 -17.44 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -74.57% -52.81% -86.41% -41.90% -52.75% -454.67% -1265.12% 0 0 -132.75% -24.65% PAT Growth 0.00% - - - - - - - - - EPS -20.61 -13.13 -13.37 -9.26 -8.25 -7.43 -7.56 -3.63 -2.01 -7.04 -8.07

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13 Mar 12
Shareholder's Funds -42.73 -25.00 -14.29 -17.78 1.48 13.01 18.28 3.60 7.95 23.15 Share Capital 19.62 18.00 16.63 13.74 13.74 13.06 9.51 9.51 9.51 9.51 Total Reserves -66.52 -50.65 -30.92 -31.52 -12.27 -3.72 -14.08 -5.91 -1.57 13.64 Non-Current Liabilities 153.76 115.66 101.79 101.37 88.88 73.88 60.12 23.02 57.33 65.53 Secured Loans 0.00 0.00 0.00 1.89 5.03 21.40 14.00 15.00 48.70 59.09 Unsecured Loans 100.55 65.51 50.23 49.78 37.76 3.91 43.61 7.32 8.35 5.67 Long Term Provisions 2.56 2.46 4.04 3.68 2.82 3.57 3.83 2.02 2.00 1.74 Current Liabilities 48.19 43.13 54.86 42.28 31.72 29.52 28.72 109.84 70.64 58.93 Trade Payables 20.78 22.65 21.44 17.76 10.99 12.37 16.54 19.79 19.75 27.34 Other Current Liabilities 25.92 18.50 32.00 23.27 19.86 16.34 12.09 84.67 31.92 16.26 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.48 18.73 15.17 Short Term Provisions 1.49 1.99 1.43 1.25 0.87 0.82 0.09 1.90 0.24 0.16 Total Liabilities 159.22 133.79 142.36 125.87 122.08 116.41 107.12 136.46 135.92 147.61 Net Block 117.93 105.29 101.27 100.77 102.17 93.10 50.98 50.58 50.63 58.47 Gross Block 260.88 243.11 234.41 229.51 226.55 213.24 166.84 164.25 164.31 163.87 Accumulated Depreciation 142.95 137.82 133.15 128.74 124.38 120.14 115.86 113.66 113.67 105.40 Non Current Assets 137.80 114.94 111.39 108.64 109.10 107.03 92.26 97.66 97.49 104.59 Capital Work in Progress 11.94 4.19 3.48 3.73 3.50 10.54 7.46 7.13 7.13 6.96 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 7.71 5.24 6.22 3.72 3.23 3.19 33.82 39.95 39.73 39.16 Other Non Current Assets 0.23 0.21 0.42 0.41 0.20 0.20 0.00 0.00 0.00 0.00 Current Assets 21.42 18.86 30.98 17.24 12.97 9.39 14.87 38.81 38.43 43.02 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 16.60 15.00 8.96 11.73 5.45 5.64 5.45 30.82 30.82 30.49 Sundry Debtors 0.30 0.20 2.91 0.32 1.59 0.03 0.37 0.62 0.92 7.74 Cash & Bank 0.71 0.17 17.32 0.42 0.12 0.27 6.31 0.36 0.33 0.43 Other Current Assets 3.80 0.31 0.21 0.33 5.81 3.46 2.74 7.01 6.35 4.36 Short Term Loans & Adv. 3.33 3.18 1.57 4.44 5.67 3.38 0.59 5.41 4.91 2.88 Net Current Assets -26.77 -24.27 -23.88 -25.04 -18.74 -20.14 -13.86 -71.03 -32.21 -15.92 Total Assets 159.22 133.80 142.37 125.88 122.07 116.42 107.13 136.47 135.92 147.61

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13 Mar 12
Cash From Operating Activity -14.57 -35.50 3.90 -6.19 -11.20 -15.26 -45.26 49.24 -1.55 7.32 PBT -28.36 -28.87 -20.12 -16.61 -16.05 -16.60 -10.79 -4.10 -15.94 -19.34 Adjustment 11.68 8.95 10.31 6.46 10.67 3.45 8.84 0.22 2.76 15.56 Changes in Working Capital 2.11 -15.58 13.71 9.12 -2.33 -1.38 -39.28 54.65 12.37 19.82 Cash after chg. in Working capital -14.57 -35.50 3.90 -1.02 -7.71 -14.53 -41.23 50.76 -0.81 16.04 Interest Paid 0.00 0.00 0.00 -5.17 -3.49 -0.74 -4.03 -1.53 -0.63 -8.66 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.11 -0.06 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -22.55 -10.22 -4.32 -2.77 -4.70 -4.00 -2.92 0.07 5.54 -1.20 Net Fixed Assets -25.52 -9.41 -4.65 -3.19 -6.27 -49.48 -2.92 0.06 -0.61 -3.95 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 2.97 -0.81 0.33 0.42 1.57 45.48 0.00 0.01 6.15 2.75 Cash from Financing Activity 37.66 28.58 17.32 9.26 15.75 13.22 54.13 -49.28 -4.09 -6.06 Net Cash Inflow / Outflow 0.54 -17.14 16.90 0.30 -0.15 -6.04 5.95 0.03 -0.10 0.07 Opening Cash & Equivalents 0.17 17.32 0.42 0.12 0.27 6.31 0.36 0.33 0.43 0.37 Closing Cash & Equivalent 0.71 0.17 17.32 0.42 0.12 0.27 6.31 0.36 0.33 0.43

Financial Ratios

Standalone

Right to Left

Description Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Sep 14 Jun 13 Mar 12
Book Value (Rs.) -23.91 -18.14 -8.59 -12.49 1.04 6.91 -4.63 3.66 8.07 23.50 ROA -19.36% -20.91% -14.92% -14.38% -13.46% -14.60% -6.44% -3.19% -10.72% -11.46% ROE 0.00% 0.00% 0.00% 0.00% -296.70% -683.34% 0.00% -75.26% -97.77% -55.86% ROCE -44.33% -56.96% -35.41% -28.95% -27.13% -25.38% -4.33% -3.91% -14.60% -9.06% Fixed Asset Turnover 0.21 0.14 0.21 0.15 0.02 0.01 0.00 0.00 0.07 0.47 Receivable days 1.71 17.00 12.36 10.34 83.55 51.87 0.00 0.00 130.58 50.71 Inventory Days 107.38 130.87 79.07 92.84 573.34 1435.63 0.00 0.00 925.22 143.77 Payable days 305.42 148.85 123.16 120.44 290.43 338.13 1500.06 2505.25 277.77 107.23 Cash Conversion Cycle -196.34 -0.98 -31.73 -17.27 366.46 1149.37 -1500.06 -2505.25 778.03 87.24 Total Debt/Equity -2.16 -2.03 -3.74 -3.16 32.19 3.27 -13.34 25.86 11.65 3.72 Interest Cover -3.52 -3.81 -2.18 -2.45 -3.60 -21.09 -0.95 -45.92 -24.33 -1.23

Top Investors:

sun pharmaceutical industries limited

Annual Reports:

News Update:

Krebs Biochem.&Inds - Quarterly Results
23rd May 2022, 15:04 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback